ImportRefusal LogoImportRefusal

Novartis Argentina

⚠️ Moderate Risk

FEI: 3011818824 • Buenos Aires • ARGENTINA

FEI

FEI Number

3011818824

📍

Location

Buenos Aires

🇦🇷

Country

ARGENTINA
🏢

Address

Ramallo 1831 Cp 1429, , Buenos Aires, , Argentina

Moderate Risk

FDA Import Risk Assessment

49.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
2
Unique Violations
3/21/2025
Latest Refusal
3/21/2025
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
11.2×30%
Recency
83.6×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
3/21/2025
61PDA55METFORMIN HCL (ANTI-DIABETIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Novartis Argentina's FDA import refusal history?

Novartis Argentina (FEI: 3011818824) has 1 FDA import refusal record(s) in our database, spanning from 3/21/2025 to 3/21/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novartis Argentina's FEI number is 3011818824.

What types of violations has Novartis Argentina received?

Novartis Argentina has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novartis Argentina come from?

All FDA import refusal data for Novartis Argentina is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.